CUSIP No. 09071M106
4 of 8 Pages
|Item 1.||(a) Name of Issuer:
|(b) Address of Issuer’s Principal
2 HaMa’ayan Street
Modi’in 7177871, Israel
|Item 2.||(a) Name of Person Filing:
Schedule 13G is being filed by each of the following persons (each, a “Reporting Person” and together, the
OrbiMed Israel BioFund GP Limited Partnership (“OrbiMed BioFund”); and
OrbiMed Israel GP Ltd. (“OrbiMed Israel”).
Exhibit A for the Reporting Persons’ agreement for a joint filing of a single statement on their behalf.
of Principal Business Office:
The address of the principal business office of each of OrbiMed BioFund and OrbiMed Israel is 89 Medinat HaYehudim St., Build
E, 11th Floor, Herzliya 46766, Israel.
Each Reporting Person was organized under the laws of the State of Israel
| ||(d) Title of Class of Securities:
Shares, NIS 0.01 par value (the “Ordinary Shares”)